Stark Michael J, Crawford Tara M, Ziegler Nina M, Hall Anthea, Andersen Chad C
Department of Neonatal Medicine, The Women's and Children's Hospital, North Adelaide, SA, Australia.
Robinson Research Institute, School of Medicine, The University of Adelaide, Adelaide, SA, Australia.
Front Pediatr. 2022 Oct 3;10:979112. doi: 10.3389/fped.2022.979112. eCollection 2022.
Ibuprofen is preferred to indomethacin for treatment of a significant patent ductus arteriosus (PDA) in preterm babies despite indomethacin being associated with a lower risk of intraventricular haemorrhage. This difference is thought to relate to the discrepant effects of each medication on cerebral oxygen kinetics yet the effect of ibuprofen on cerebral perfusion is uncertain.
Forty-eight babies < 30 weeks with a significant PDA, defined by echocardiography, were randomly assigned to either indomethacin or ibuprofen ( = 24 per group) and stratified by gestation and chronologic age. Cerebral blood flow [total internal carotid blood flow (TICF)] and oxygen physiology [oxygen delivery (modCerbDO) and consumption (modCerbVO)] were measured using cranial Doppler ultrasound and near-infrared spectroscopy, and cerebral oxygen extraction (cFTOE) calculated, immediately before and following administration. Temporal and treatment related changes were analysed.
A fixed effect of time was seen for TICF ( = 0.03) and therefore modCerbDO ( = 0.046) and cFTOE ( = 0.04) for indomethacin alone. In the indomethacin group, TICF and modCerbDO fell from baseline to 5 and 30 min respectively (TICF < 0.01, cDO = 0.01) before increasing from 5 min to 24 h ( < 0.01) and 30 min and 24 h ( < 0.01) timepoints. cFTOE peaked at 30 min ( = 0.02) returning to baseline at 24 h. There was a parallel increase in arterial lactate.
Indomethacin significantly reduces cerebral blood flow soon after administration, resulting in a parallel increase in oxygen extraction and arterial lactate. This implies that the balance of oxygen kinetics at the time of treatment may be critical in very preterm babies with significant PDA.
尽管吲哚美辛与较低的脑室内出血风险相关,但在治疗早产儿显著动脉导管未闭(PDA)时,布洛芬比吲哚美辛更受青睐。这种差异被认为与每种药物对脑氧动力学的不同影响有关,但布洛芬对脑灌注的影响尚不确定。
48名孕周<30周、经超声心动图确诊为显著PDA的婴儿被随机分为吲哚美辛组或布洛芬组(每组24名),并按孕周和实际年龄分层。在给药前后即刻,使用经颅多普勒超声和近红外光谱测量脑血流量[颈内动脉总血流量(TICF)]和氧生理学指标[氧输送量(modCerbDO)和消耗量(modCerbVO)],并计算脑氧摄取率(cFTOE)。分析时间和治疗相关的变化。
仅使用吲哚美辛时,TICF(P = 0.03)以及因此modCerbDO(P = 0.046)和cFTOE(P = 0.04)存在时间的固定效应。在吲哚美辛组中,TICF和modCerbDO分别从基线下降至5分钟和30分钟(TICF P < 0.01,cDO P = 0.01),然后在5分钟至24小时(P < 0.01)以及30分钟和24小时(P < 0.01)时间点从5分钟开始增加。cFTOE在30分钟时达到峰值(P = 0.02),在24小时时恢复到基线。动脉乳酸水平平行升高。
吲哚美辛给药后不久会显著降低脑血流量,导致氧摄取率和动脉乳酸水平平行升高。这意味着在患有显著PDA的极早产儿中,治疗时的氧动力学平衡可能至关重要。